Basal Cell Carcinoma Treatment Market (2024 - 2030) Size, Share & Trends Analysis Report By Treatment Type (Surgery, Radiotherapy, Topical Chemotherapy, Intralesional Injections, Oral Medications, Chemical Peeling Treatment), By Region, And Segment Forecasts

Market Segmentation

• Basal Cell Carcinoma Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Surgery
    • Mohs surgery
    • Surgical Excision
    • Electrodesiccation and Curettage (ED&C)
  • Radiotherapy (RT)
  • Intralesional injections
  • Topical chemotherapy
    • 5-fluorouracil (5-FU)
    • Tirbanibulin (Klisyri)
    • Imiquimod (Zyclara)
  • Oral Medications
    • Vismodegib (Erivedge)
    • Sonidegib (Odomzo)
  • Intravenous Medications
  • Chemical peeling treatment
• Basal Cell Carcinoma Treatment Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • North America Basal Cell Carcinoma Market, By Treatment Type 
      • Surgery
        • Mohs surgery
        • Surgical Excision
        • Electrodesiccation and Curettage (ED&C)
      • Radiotherapy (RT)
      • Intralesional injections
      • Topical chemotherapy
        • 5-fluorouracil (5-FU)
        • Tirbanibulin (Klisyri)
        • Imiquimod (Zyclara)
      • Oral Medications
        • Vismodegib (Erivedge)
        • Sonidegib (Odomzo)
      • Intravenous Medications
      • Chemical peeling treatment
    • U.S.
      • U.S. Basal Cell Carcinoma Market, By Treatment Type 
        • Surgery
          • Mohs surgery
          • Surgical Excision
          • Electrodesiccation and Curettage (ED&C)
        • Radiotherapy (RT)
        • Intralesional injections
        • Topical chemotherapy
          • 5-fluorouracil (5-FU)
          • Tirbanibulin (Klisyri)
          • Imiquimod (Zyclara)
        • Oral Medications
          • Vismodegib (Erivedge)
          • Sonidegib (Odomzo)
        • Intravenous Medications
        • Chemical peeling treatment
    • Canada
      • Canada Basal Cell Carcinoma Market, By Treatment Type 
        • Surgery
          • Mohs surgery
          • Surgical Excision
          • Electrodesiccation and Curettage (ED&C)
        • Radiotherapy (RT)
        • Intralesional injections
        • Topical chemotherapy
          • 5-fluorouracil (5-FU)
          • Tirbanibulin (Klisyri)
          • Imiquimod (Zyclara)
        • Oral Medications
          • Vismodegib (Erivedge)
          • Sonidegib (Odomzo)
        • Intravenous Medications
        • Chemical peeling treatment
    • Mexico
      • Mexico Basal Cell Carcinoma Market, By Treatment Type 
        • Surgery
          • Mohs surgery
          • Surgical Excision
          • Electrodesiccation and Curettage (ED&C)
        • Radiotherapy (RT)
        • Intralesional injections
        • Topical chemotherapy
          • 5-fluorouracil (5-FU)
          • Tirbanibulin (Klisyri)
          • Imiquimod (Zyclara)
        • Oral Medications
          • Vismodegib (Erivedge)
          • Sonidegib (Odomzo)
        • Intravenous Medications
        • Chemical peeling treatment
  • Europe
    • Europe Basal Cell Carcinoma Market, By Treatment Type 
      • Surgery
        • Mohs surgery
        • Surgical Excision
        • Electrodesiccation and Curettage (ED&C)
      • Radiotherapy (RT)
      • Intralesional injections
      • Topical chemotherapy
        • 5-fluorouracil (5-FU)
        • Tirbanibulin (Klisyri)
        • Imiquimod (Zyclara)
      • Oral Medications
        • Vismodegib (Erivedge)
        • Sonidegib (Odomzo)
      • Intravenous Medications
      • Chemical peeling treatment
    • Germany
      • Germany Basal Cell Carcinoma Market, By Treatment Type 
        • Surgery
          • Mohs surgery
          • Surgical Excision
          • Electrodesiccation and Curettage (ED&C)
        • Radiotherapy (RT)
        • Intralesional injections
        • Topical chemotherapy
          • 5-fluorouracil (5-FU)
          • Tirbanibulin (Klisyri)
          • Imiquimod (Zyclara)
        • Oral Medications
          • Vismodegib (Erivedge)
          • Sonidegib (Odomzo)
        • Intravenous Medications
        • Chemical peeling treatment
    • UK
      • UK Basal Cell Carcinoma Market, By Treatment Type 
        • Surgery
          • Mohs surgery
          • Surgical Excision
          • Electrodesiccation and Curettage (ED&C)
        • Radiotherapy (RT)
        • Intralesional injections
        • Topical chemotherapy
          • 5-fluorouracil (5-FU)
          • Tirbanibulin (Klisyri)
          • Imiquimod (Zyclara)
        • Oral Medications
          • Vismodegib (Erivedge)
          • Sonidegib (Odomzo)
        • Intravenous Medications
        • Chemical peeling treatment
    • France
      • France Basal Cell Carcinoma Market, By Treatment Type 
        • Surgery
          • Mohs surgery
          • Surgical Excision
          • Electrodesiccation and Curettage (ED&C)
        • Radiotherapy (RT)
        • Intralesional injections
        • Topical chemotherapy
          • 5-fluorouracil (5-FU)
          • Tirbanibulin (Klisyri)
          • Imiquimod (Zyclara)
        • Oral Medications
          • Vismodegib (Erivedge)
          • Sonidegib (Odomzo)
        • Intravenous Medications
        • Chemical peeling treatment
    • Italy
      • Italy Basal Cell Carcinoma Market, By Treatment Type 
        • Surgery
          • Mohs surgery
          • Surgical Excision
          • Electrodesiccation and Curettage (ED&C)
        • Radiotherapy (RT)
        • Intralesional injections
        • Topical chemotherapy
          • 5-fluorouracil (5-FU)
          • Tirbanibulin (Klisyri)
          • Imiquimod (Zyclara)
        • Oral Medications
          • Vismodegib (Erivedge)
          • Sonidegib (Odomzo)
        • Intravenous Medications
        • Chemical peeling treatment
    • Spain
      • Spain Basal Cell Carcinoma Market, By Treatment Type 
        • Surgery
          • Mohs surgery
          • Surgical Excision
          • Electrodesiccation and Curettage (ED&C)
        • Radiotherapy (RT)
        • Intralesional injections
        • Topical chemotherapy
          • 5-fluorouracil (5-FU)
          • Tirbanibulin (Klisyri)
          • Imiquimod (Zyclara)
        • Oral Medications
          • Vismodegib (Erivedge)
          • Sonidegib (Odomzo)
        • Intravenous Medications
        • Chemical peeling treatment
    • Denmark
      • Denmark Basal Cell Carcinoma Market, By Treatment Type 
        • Surgery
          • Mohs surgery
          • Surgical Excision
          • Electrodesiccation and Curettage (ED&C)
        • Radiotherapy (RT)
        • Intralesional injections
        • Topical chemotherapy
          • 5-fluorouracil (5-FU)
          • Tirbanibulin (Klisyri)
          • Imiquimod (Zyclara)
        • Oral Medications
          • Vismodegib (Erivedge)
          • Sonidegib (Odomzo)
        • Intravenous Medications
        • Chemical peeling treatment
    • Sweden
      • Sweden Basal Cell Carcinoma Market, By Treatment Type 
        • Surgery
          • Mohs surgery
          • Surgical Excision
          • Electrodesiccation and Curettage (ED&C)
        • Radiotherapy (RT)
        • Intralesional injections
        • Topical chemotherapy
          • 5-fluorouracil (5-FU)
          • Tirbanibulin (Klisyri)
          • Imiquimod (Zyclara)
        • Oral Medications
          • Vismodegib (Erivedge)
          • Sonidegib (Odomzo)
        • Intravenous Medications
        • Chemical peeling treatment
    • Norway
      • Norway Basal Cell Carcinoma Market, By Treatment Type 
        • Surgery
          • Mohs surgery
          • Surgical Excision
          • Electrodesiccation and Curettage (ED&C)
        • Radiotherapy (RT)
        • Intralesional injections
        • Topical chemotherapy
          • 5-fluorouracil (5-FU)
          • Tirbanibulin (Klisyri)
          • Imiquimod (Zyclara)
        • Oral Medications
          • Vismodegib (Erivedge)
          • Sonidegib (Odomzo)
        • Intravenous Medications
        • Chemical peeling treatment
  • Asia Pacific
    • Asia Pacific Basal Cell Carcinoma Market, By Treatment Type 
      • Surgery
        • Mohs surgery
        • Surgical Excision
        • Electrodesiccation and Curettage (ED&C)
      • Radiotherapy (RT)
      • Intralesional injections
      • Topical chemotherapy
        • 5-fluorouracil (5-FU)
        • Tirbanibulin (Klisyri)
        • Imiquimod (Zyclara)
      • Oral Medications
        • Vismodegib (Erivedge)
        • Sonidegib (Odomzo)
      • Intravenous Medications
      • Chemical peeling treatment
    • China
      • China Basal Cell Carcinoma Market, By Treatment Type 
        • Surgery
          • Mohs surgery
          • Surgical Excision
          • Electrodesiccation and Curettage (ED&C)
        • Radiotherapy (RT)
        • Intralesional injections
        • Topical chemotherapy
          • 5-fluorouracil (5-FU)
          • Tirbanibulin (Klisyri)
          • Imiquimod (Zyclara)
        • Oral Medications
          • Vismodegib (Erivedge)
          • Sonidegib (Odomzo)
        • Intravenous Medications
        • Chemical peeling treatment
    • Japan
      • Japan Basal Cell Carcinoma Market, By Treatment Type 
        • Surgery
          • Mohs surgery
          • Surgical Excision
          • Electrodesiccation and Curettage (ED&C)
        • Radiotherapy (RT)
        • Intralesional injections
        • Topical chemotherapy
          • 5-fluorouracil (5-FU)
          • Tirbanibulin (Klisyri)
          • Imiquimod (Zyclara)
        • Oral Medications
          • Vismodegib (Erivedge)
          • Sonidegib (Odomzo)
        • Intravenous Medications
        • Chemical peeling treatment
    • India
      • India Basal Cell Carcinoma Market, By Treatment Type 
        • Surgery
          • Mohs surgery
          • Surgical Excision
          • Electrodesiccation and Curettage (ED&C)
        • Radiotherapy (RT)
        • Intralesional injections
        • Topical chemotherapy
          • 5-fluorouracil (5-FU)
          • Tirbanibulin (Klisyri)
          • Imiquimod (Zyclara)
        • Oral Medications
          • Vismodegib (Erivedge)
          • Sonidegib (Odomzo)
        • Intravenous Medications
        • Chemical peeling treatment
    • South Korea
      • South Korea Basal Cell Carcinoma Market, By Treatment Type 
        • Surgery
          • Mohs surgery
          • Surgical Excision
          • Electrodesiccation and Curettage (ED&C)
        • Radiotherapy (RT)
        • Intralesional injections
        • Topical chemotherapy
          • 5-fluorouracil (5-FU)
          • Tirbanibulin (Klisyri)
          • Imiquimod (Zyclara)
        • Oral Medications
          • Vismodegib (Erivedge)
          • Sonidegib (Odomzo)
        • Intravenous Medications
        • Chemical peeling treatment
    • Australia
      • Australia Basal Cell Carcinoma Market, By Treatment Type 
        • Surgery
          • Mohs surgery
          • Surgical Excision
          • Electrodesiccation and Curettage (ED&C)
        • Radiotherapy (RT)
        • Intralesional injections
        • Topical chemotherapy
          • 5-fluorouracil (5-FU)
          • Tirbanibulin (Klisyri)
          • Imiquimod (Zyclara)
        • Oral Medications
          • Vismodegib (Erivedge)
          • Sonidegib (Odomzo)
        • Intravenous Medications
        • Chemical peeling treatment
    • Thailand
      • Thailand Basal Cell Carcinoma Market, By Treatment Type 
        • Surgery
          • Mohs surgery
          • Surgical Excision
          • Electrodesiccation and Curettage (ED&C)
        • Radiotherapy (RT)
        • Intralesional injections
        • Topical chemotherapy
          • 5-fluorouracil (5-FU)
          • Tirbanibulin (Klisyri)
          • Imiquimod (Zyclara)
        • Oral Medications
          • Vismodegib (Erivedge)
          • Sonidegib (Odomzo)
        • Intravenous Medications
        • Chemical peeling treatment
  • Latin America
    • Latin America Basal Cell Carcinoma Market, By Treatment Type 
      • Surgery
        • Mohs surgery
        • Surgical Excision
        • Electrodesiccation and Curettage (ED&C)
      • Radiotherapy (RT)
      • Intralesional injections
      • Topical chemotherapy
        • 5-fluorouracil (5-FU)
        • Tirbanibulin (Klisyri)
        • Imiquimod (Zyclara)
      • Oral Medications
        • Vismodegib (Erivedge)
        • Sonidegib (Odomzo)
      • Intravenous Medications
      • Chemical peeling treatment
    • Brazil
      • Brazil Basal Cell Carcinoma Market, By Treatment Type 
        • Surgery
          • Mohs surgery
          • Surgical Excision
          • Electrodesiccation and Curettage (ED&C)
        • Radiotherapy (RT)
        • Intralesional injections
        • Topical chemotherapy
          • 5-fluorouracil (5-FU)
          • Tirbanibulin (Klisyri)
          • Imiquimod (Zyclara)
        • Oral Medications
          • Vismodegib (Erivedge)
          • Sonidegib (Odomzo)
        • Intravenous Medications
        • Chemical peeling treatment
    • Argentina
      • Argentina Basal Cell Carcinoma Market, By Treatment Type 
        • Surgery
          • Mohs surgery
          • Surgical Excision
          • Electrodesiccation and Curettage (ED&C)
        • Radiotherapy (RT)
        • Intralesional injections
        • Topical chemotherapy
          • 5-fluorouracil (5-FU)
          • Tirbanibulin (Klisyri)
          • Imiquimod (Zyclara)
        • Oral Medications
          • Vismodegib (Erivedge)
          • Sonidegib (Odomzo)
        • Intravenous Medications
        • Chemical peeling treatment
  • Middle East and Africa (MEA)
    • MEA Basal Cell Carcinoma Market, By Treatment Type 
      • Surgery
        • Mohs surgery
        • Surgical Excision
        • Electrodesiccation and Curettage (ED&C)
      • Radiotherapy (RT)
      • Intralesional injections
      • Topical chemotherapy
        • 5-fluorouracil (5-FU)
        • Tirbanibulin (Klisyri)
        • Imiquimod (Zyclara)
      • Oral Medications
        • Vismodegib (Erivedge)
        • Sonidegib (Odomzo)
      • Intravenous Medications
      • Chemical peeling treatment
    • South Africa
      • South Africa Basal Cell Carcinoma Market, By Treatment Type 
        • Surgery
          • Mohs surgery
          • Surgical Excision
          • Electrodesiccation and Curettage (ED&C)
        • Radiotherapy (RT)
        • Intralesional injections
        • Topical chemotherapy
          • 5-fluorouracil (5-FU)
          • Tirbanibulin (Klisyri)
          • Imiquimod (Zyclara)
        • Oral Medications
          • Vismodegib (Erivedge)
          • Sonidegib (Odomzo)
        • Intravenous Medications
        • Chemical peeling treatment
    • Saudi Arabia
      • Saudi Arabia Basal Cell Carcinoma Market, By Treatment Type 
        • Surgery
          • Mohs surgery
          • Surgical Excision
          • Electrodesiccation and Curettage (ED&C)
        • Radiotherapy (RT)
        • Intralesional injections
        • Topical chemotherapy
          • 5-fluorouracil (5-FU)
          • Tirbanibulin (Klisyri)
          • Imiquimod (Zyclara)
        • Oral Medications
          • Vismodegib (Erivedge)
          • Sonidegib (Odomzo)
        • Intravenous Medications
        • Chemical peeling treatment
    • Kuwait
      • Kuwait Basal Cell Carcinoma Market, By Treatment Type 
        • Surgery
          • Mohs surgery
          • Surgical Excision
          • Electrodesiccation and Curettage (ED&C)
        • Radiotherapy (RT)
        • Intralesional injections
        • Topical chemotherapy
          • 5-fluorouracil (5-FU)
          • Tirbanibulin (Klisyri)
          • Imiquimod (Zyclara)
        • Oral Medications
          • Vismodegib (Erivedge)
          • Sonidegib (Odomzo)
        • Intravenous Medications
        • Chemical peeling treatment
    • UAE
      • UAE Basal Cell Carcinoma Market, By Treatment Type 
        • Surgery
          • Mohs surgery
          • Surgical Excision
          • Electrodesiccation and Curettage (ED&C)
        • Radiotherapy (RT)
        • Intralesional injections
        • Topical chemotherapy
          • 5-fluorouracil (5-FU)
          • Tirbanibulin (Klisyri)
          • Imiquimod (Zyclara)
        • Oral Medications
          • Vismodegib (Erivedge)
          • Sonidegib (Odomzo)
        • Intravenous Medications
        • Chemical peeling treatment

Report content

Qualitative Analysis

• Industry overview
• Industry trends
• Market drivers and restraints
• Market size
• Growth prospects
• Porter’s analysis
• PESTEL analysis
• Key market opportunities prioritized
• Competitive landscape
  • Company overview
  • Financial performance
  • Product benchmarking
  • Latest strategic developments

Quantitative Analysis

• Market size, estimates, and forecast from 2018 to 2030
• Market estimates and forecast for product segments up to 2030
• Regional market size and forecast for product segments up to 2030
• Market estimates and forecast for application segments up to 2030
• Regional market size and forecast for application segments up to 2030
• Company financial performance